Colorado AG Cites Feldman and C4i’s Research in Insulin Report
Key subsection titled “The Feldman Report” finds state’s insulin costs Increased by 280%. The Colorado Department of Law released a report earlier this month on…
Center for Innovation (C4i) News
Post List
Feldman Wins Goldberg Memorial Lecture Award for Pharma Policy Work
Prof. Robin Feldman has been honored with the 2020 Leon I. Goldberg Memorial Lecture Award by the University of Chicago’s Committee on Clinical Pharmacology and…
Startup Legal Garage Celebrates Nobel for Jennifer A. Doudna
The year was 2012. Few if any specialists outside of scientific labs knew what CRISPR stood for, let alone what the technology could do. But a small, select group of UC…
Patent Database Exposes Pharma’s Pricey “Evergreen” Strategy
AstraZeneca, Johnson & Johnson and Gilead lead a crowded field of drug makers who excessively extend patent protections to limit the market entry of competing…
Robin Feldman Launches Pandemic Research Project
The UC Hastings Center for Innovation has launched a COVID-19 research project to study how information, especially regarding health care, flows during times of pandemic,…
Robin Feldman Pens Washington Post Op-Ed on Vaccine and Drug Pricing
Professor Robin Feldman published an op-ed in the Washington Post in response to Health and Human Services Secretary Alex Azar’s comment that he couldn’t promise…
C4i Issues Presidential Advisory Memo on Health Care Policy
Americans have ranked health care as one of the issues most important to them. In early 2020, the nonpartisan Law & Medicine Initiative at the…
C4i Presidential Advisory Memo: Recent Evidence in Health Care Policy
Date: February 2020* To: 2020 Presidential Campaigns From: Robin Feldman, Arthur J. Goldberg Distinguished Professor of Law and Director, Center for Innovation (C4i)…
The World Comes to UC Hastings
UC Hastings has long been a magnet for scholars, students, and practicing attorneys from throughout the world. In the past decade, one key reason for…
Inside Big Pharma
Treatments for hemophilia could soon top $1.5 million a year. A drug for childhood leukemia recently debuted with a price tag of $475,000. Prescription drug…
UC Hastings Law Professor Lefstin Testifies Before Senate on U.S. Patent Eligibility
UC Hastings Law Professor and Associate Academic Dean Jeffrey Lefstin testified before the Senate Committee on the Judiciary, Subcommittee on Intellectual Property this week about…
UC Hastings Law Fuels Academic Innovation with Five New Centers
UC Hastings College of the Law inaugurated a handful of new programmatic centers this fall, each designed to provide innovative educational opportunities as well as…